314
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Cost-effectiveness of a voucher-based intervention for smoking cessation

, MA, , PhD, , PhD & , PhD
Pages 296-305 | Received 09 Mar 2015, Accepted 07 Aug 2015, Published online: 20 Oct 2015

References

  • Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006;101:1546–1560.
  • Stitzer M, Petry N. Contingency management for treatment of substance abuse. Ann Rev Clin Psychol 2006;2:411–434.
  • Tracy K, Babuscio T, Nich C, Kiluk B, Carroll KM, Petry NM, Rounsaville BJ. Contingency management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders. Am J Drug Alcohol Abuse 2007;33:253–258.
  • Higgins ST, Silverman K, Heil SH. Contingency management in substance abuse treatment. New York, NY: The Guilford Press; 2008.
  • Ledgerwood DM. Contingency management for smoking cessation: where do we go from here? Curr Drug Abuse Rev 2008;1:340–349.
  • Sigmon SC, Patrick ME. The use of financial incentives in promoting smoking cessation. Prev Med 2012;55(Suppl.):S24–32.
  • Petry NM, Alessi SM, Ledgerwood DM. Contingency management delivered by community therapists in outpatient settings. Drug Alcohol Depend 2012;122:86–92.
  • McPherson S, Packer RR, Cameron JM, Howell DN, Roll JM. Biochemical marker of use is a better predictor of outcomes than self-report metrics in a contingency management smoking cessation analog study. Am J Addict 2014;23:15–20.
  • Alessi SM, Badger GJ, Higgins ST. An experimental examination of the initial weeks of abstinence in cigarette smokers. Exp Clin Psychopharmacol 2004;12:276–287.
  • Heil SH, Tidey JW, Holmes HW, Badger GJ, Higgins ST. A contingent payment model of smoking cessation: effects on abstinence and withdrawal. Nicotine Tob Res 2003;5:205–213.
  • Dallery J, Glenn IM, Raiff BR. An internet-based abstinence reinforcement treatment for cigarette smoking. Drug Alcohol Depend 2007;86:230–238.
  • Lamb RJ, Kirby KC, Morral AR, Galbicka G, Iguchi MY. Shaping smoking cessation in hard-to-treat smokers. J Consult Clin Psychol 2010;78:62–71.
  • Alessi SM, Petry NM, Urso J. Contingency management promotes smoking reductions in residential substance abuse patients. J Appl Behav Anal 2008;41:617–622.
  • Robles E, Crone CC, Whiteside-Mansell L, Conners NA, Bokony PA, Worley LL, McMillan DE. Voucher-based incentives for cigarette smoking reduction in a women’s residential treatment program. Nicotine Tob Res 2005;7:111–117.
  • García-Fernández G, Secades-Villa R, García-Rodríguez O, Álvarez-López H, Fernández-Hermida JR, Fernández-Artamendi S, Higgins ST. Long-term benefits of adding incentives to the community reinforcement approach for cocaine dependence. Eur Addict Res 2011;17:139–145.
  • Krishnan-Sarin S, Duhig AM, McKee SA, McMahon TJ, Liss T, McFetridge A, Cavallo DA. Contingency management for smoking cessation in adolescent smokers. Exp Clin Psychopharmacol 2006;14:306–310.
  • Tevyaw TO, Colby SM, Tidey JW, Kahler CW, Rohsenow DJ, Barnett NP, Gwaltney CJ, et al. Contingency management and motivational enhancement: a randomized clinical trial for college student smokers. Nicotine Tob Res 2009;11:739–749.
  • Donatelle R, Hudson D, Dobie S, Goodall A, Hunsberger M, Oswald K. Incentives in smoking cessation: status of the field and implications for research and practice with pregnant smokers. Nicotine Tob Res 2004;6(Suppl. 2):S163–179.
  • Higgins ST, Washio Y, Heil SH, Solomon LJ, Gaalema DE, Higgins TM, Bernstein IM. Financial incentives for smoking cessation among pregnant and newly postpartum women. Prev Med 2012;55:S33–40.
  • Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology (Berl) 2011;217:279–287.
  • Volpp KG, Levy AG, Asch DA, Berlin JA, Murphy JJ, Gomez A, Sox H, et al. A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prev 2006;15:12–18.
  • Carroll KM, Rounsaville BJ. A perfect platform: combining contingency management with medications for drug abuse. Am J Drug Alcohol Abuse 2007;33:343–365.
  • Alessi SM, Hanson T, Wieners M, Petry NM. Low-cost contingency management in community clinics: delivering incentives partially in group therapy. Exp Clin Psychopharmacol 2007;15:293–300.
  • Hartzler B, Lash SJ, Roll JM. Contingency management in substance abuse treatment: a structured review of the evidence for its transportability. Drug Alcohol Depend 2012;122:1–10.
  • Petry NM, Tedford J, Austin M, Nich C, Carroll KM, Rounsaville BJ. Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? Addiction 2004;99:349–360.
  • Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry 2005;62:1148–1156.
  • Roll JM, Chudzynski JE, Richardson G. Potential sources of reinforcement and punishment in a drug-free treatment clinic: client and staff perceptions. Am J Drug Alcohol Abuse 2005;31:21–33.
  • García-Rodríguez O, Secades-Villa R, Higgins ST, Fernández-Hermida JR, Carballo JL. Financing a voucher program for cocaine abusers through community donations in Spain. J Appl Behav Anal 2008;41:623–628.
  • Olmstead TA, Sindelar JL, Petry NM. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend 2007;87:175–182.
  • Olmstead TA, Petry NM. The cost-effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients. Drug Alcohol Depend 2009;102:108–115.
  • Sindelar JL, Olmstead TA, Peirce JM. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction 2007;102:1463–1471.
  • Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians’ smoking cessation counseling. JAMA 1996;275:1247–1251.
  • von Wartburg M, Raymond V, Paradis PE. The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada. Int J Clin Pract 2014;68:639–646.
  • Smit ES, Evers SM, de Vries H, Hoving C. Cost-effectiveness and cost-utility of Internet-based computer tailoring for smoking cessation. J Med Internet Res 2013;15:e57.
  • Smith MW, An LC, Fu SS, Nelson DB, Joseph AM. Cost-effectiveness of an intensive telephone-based intervention for smoking cessation. J Telemed Telecare 2011;17:437–440.
  • Smith MY, Cromwell J, DePue J, Spring B, Redd W, Unrod M. Determining the cost-effectiveness of a computer-based smoking cessation intervention in primary care. Manag Care 2007;16:48–55.
  • Graham AL, Chang YJ, Fang Y, Cobb NK, Tinkelman DS, Niaura RS, Abrams DB, et al. Cost-effectiveness of internet and telephone treatment for smoking cessation: an economic evaluation of The iQUITT Study. Tob Control 2013;22(6).
  • Stanczyk NE, Smit ES, Schulz DN, de Vries H, Bolman C, Muris JW, Evers SM. An economic evaluation of a video- and text-based computer-tailored intervention for smoking cessation: a cost-effectiveness and cost-utility analysis of a randomized controlled trial. PLoS One 2014;9(10).
  • Castañal-Canto X, Martín-Miguel MV, Hervés-Beloso C, Pérez-Cachafeiro S, Espinosa-Arévalo MM, Delgado-Martín JL. Working with our smoker patients in primary care. Analysis of cost-effectiveness. Aten Primaria 2012;44:659–666.
  • White JS, Dow WH, Rungruanghiranya S. Commitment contracts and team incentives: a randomized controlled trial for smoking cessation in Thailand. Am J Prev Med 2013;45:533–542.
  • Secades-Villa R, García-Rodríguez O, López-Núñez C, Alonso-Pérez F, Fernández-Hermida JR. Contingency management for smoking cessation among treatment-seeking patients in a community setting. Drug Alcohol Depend 2014;140:63–68.
  • Becoña E, Vázquez FL. Does using relapse prevention increase the efficacy of a program for smoking cessation? An empirical study. Psychol Rep 1997;81:291–296.
  • Secades-Villa R, Alonso-Pérez F, García-Rodríguez O, Fernández-Hermida JR. Effectiveness of three intensities of smoking cessation treatment in primary care. Psychol Rep 2009;105:747–758.
  • Drummond MF, Sculpher MJ, Torrance GW, O’Brien B, Stoddart GL. Methods for the economic evaluation of health care programs, 3rd ed. Oxford, UK: Oxford University Press; 2005.
  • Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. Oxford, UK: Oxford University Press; 1996.
  • Sindelar J, Elbel B, Petry NM. What do we get for our money? Cost-effectiveness of adding contingency management. Addiction 2007;102:309–316.
  • Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779–787.
  • Fenwick E, Byford S. A guide to cost-effectiveness acceptability curves. Br J Psychiatry 2005;187:106–108.
  • Nixon RM, Wonderling D, Grieve RD. Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared. Health Econ 2010;19:316–333.
  • Willan AR. Analysis, sample size, and fewer for estimating incremental net health benefit from clinical trial data. Control Clin Trials 2001;22:228–237.
  • Metz CE, Herman BA, Shen JH. Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. Stat Med 1998;17:1033–1053.
  • Cohen D, Alam MF, Jarvis PS. An analysis of the economic impact of smoking cessation in Europe. BMC Public Health 2013;13:390.
  • Nohlert E, Helgason AR, Tillgren P, Tegelberg A, Johansson P. Comparison of the cost-effectiveness of a high- and a low-intensity smoking cessation intervention in Sweden: a randomized trial. Nicotine Tob Res 2013;15:1519–1527.
  • Wasserfallen JB, Digon P, Cornuz J. Medical and pharmacological direct costs of a 9-week smoking cessation programme. Eur J Prev Cardiol 2012;19:565–570.
  • Christenhusz LC, Prenger R, Pieterse ME, Seydel ER, van der Palen J. Cost-effectiveness of an intensive smoking cessation intervention for COPD outpatients. Nicotine Tob Res 2012;14:657–663.
  • Prenger R, Pieterse ME, Braakman-Jansen LM, van der Palen J, Christenhusz LC, Seydel ER. Moving beyond a limited follow-up in cost-effectiveness analyses of behavioral interventions. Eur J Health Econ 2013;14:297–306.
  • Banegas JR, Díez-Gañán L, Bañuelos-Marco B, González-Enríquez J, Villar-Álvarez F, Martín-Moreno JM, Córdoba-García, R, et al. Smoking-attributable deaths in Spain, 2006. Med Clin (Barc) 2011;136:97–102.
  • Becoña E, Vázquez MA, Míguez MC, Fernández del Río E, López-Durán A, Martínez Ú, Piñeiro B. Smoking habit profile and health-related quality of life. Psicothema 2013;25:421–426.
  • Bolin K. Economic evaluation of smoking-cessation therapies: a critical and systematic review of simulation models. Pharmacoeconomics 2012;30:551–564.
  • González-Enríquez J, Salvador-Llivina T, López-Nicolás A, Antón de las Heras E, Musin A, Fernández E, García M, et al. The effects of implementing a smoking cessation intervention in Spain on morbidity, mortality and health care costs. Gac Sanit 2002;16:308–317.
  • Sacristán JA, Oliva J, Del Llano J, Prieto L, Pinto JL. What is an efficient health technology in Spain? Gac Sanit 2002;16:334–343.
  • Rodríguez Barrios JM, Pérez Alcántara F, Crespo Palomo C, González García P, Antón de las Heras E, Brosa Riestra M. The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications. Eur J Health Econ 2012;13:723–740.
  • Kirby KC, Carpenedo CM, Stitzer ML, Dugosh KL, Petry NM, Roll JM, Saladin ME, et al. Is exposure to an effective contingency management intervention associated with more positive provider beliefs? J Subst Abuse Treat 2012;42:356–365.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.